Literature DB >> 2655728

A general class of nonparametric tests for survival analysis.

M P Jones1, J Crowley.   

Abstract

Tarone and Ware (1977, Biometrika 64, 156-160) developed a general class of s-sample test statistics for right-censored survival data that includes the log-rank and modified Wilcoxon procedures. Subsequently, many authors have considered two- and s-sample classes in detail. In this paper a family of nonparametric statistics is shown to unify existing and generate new test statistics for the s (greater than or equal to 2)-sample, s-sample trend, and single continuous covariate problems.

Mesh:

Year:  1989        PMID: 2655728

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  17 in total

1.  Covariate order tests for covariate effect.

Authors:  Jan Terje Kvaløy
Journal:  Lifetime Data Anal       Date:  2002-03       Impact factor: 1.588

2.  Testing and interval estimation for two-sample survival comparisons with small sample sizes and unequal censoring.

Authors:  Rui Wang; Stephen W Lagakos; Robert J Gray
Journal:  Biostatistics       Date:  2010-05-02       Impact factor: 5.899

3.  Linear signed-rank tests for paired survival data subject to a common censoring time.

Authors:  Michael P Jones; Bongin Yoo
Journal:  Lifetime Data Anal       Date:  2005-09       Impact factor: 1.588

4.  Partitioned log-rank tests for the overall homogeneity of hazard rate functions.

Authors:  Yukun Liu; Guosheng Yin
Journal:  Lifetime Data Anal       Date:  2016-03-19       Impact factor: 1.588

5.  Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

Authors:  Kimmie Ng; Jeffrey A Meyerhardt; Andrew T Chan; Kaori Sato; Jennifer A Chan; Donna Niedzwiecki; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Alan P Venook; Shuji Ogino; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2014-11-27       Impact factor: 13.506

6.  Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803.

Authors:  Kimmie Ng; Shuji Ogino; Jeffrey A Meyerhardt; Jennifer A Chan; Andrew T Chan; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Monica M Bertagnolli; Alan P Venook; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2011-08-17       Impact factor: 13.506

7.  Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.

Authors:  Kimmie Ng; Jeffrey A Meyerhardt; Jennifer A Chan; Donna Niedzwiecki; Donna R Hollis; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Charles S Fuchs
Journal:  J Clin Oncol       Date:  2010-08-30       Impact factor: 44.544

8.  Clinical outcomes of various continued antiplatelet therapies in patients who were administered DAPT following the implantation of drug-eluting stents and developed gastrointestinal hemorrhage.

Authors:  Yujie Guo; Jinru Wei
Journal:  Exp Ther Med       Date:  2016-05-23       Impact factor: 2.447

9.  Association of family history with cancer recurrence and survival among patients with stage III colon cancer.

Authors:  Jennifer A Chan; Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James Thomas; Paul Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Robert S Warren; Monica Bertagnolli; Charles S Fuchs
Journal:  JAMA       Date:  2008-06-04       Impact factor: 56.272

10.  Recognizing the problem of delayed entry in time-to-event studies: Better late than never for clinical neuroscientists.

Authors:  Rebecca A Betensky; Micha Mandel
Journal:  Ann Neurol       Date:  2015-11-13       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.